Dear friends and supporters of VSCR,
2024 was a challenging, but a successful year of performance. It brought new projects and new geographic extensions.
MAIN ACTIVITIES
In 2024, VSCR and its faculty were engaged in several Capacity Building Programs for public and institutional health policy makers/payers from various geographies. These accredited programs were designed and led by Prof. Lieven Annemans, MSc, PhD, Senior Professor of Health Economics, Ghent University, Belgium and Prof. Heinrich Klech, MD, PhD, Managing Director VSCR, Vienna and Margarete Schreiner-Karner, MSc, Operational Manager VSCR.
CAPACITY BUILDING PROGRAM IN GCC COUNTRIES
In 2024, a large number of policy makers and payers from GCC countries (UAE, Qatar, Kuwait, Oman, Bahrain) successfully have accomplished VSCR’s Diploma Programs in Health Outcome Research (HEOR) and HTA Technology.
This program was executed in cooperation with EHES (Emirates Health Economic Society) and I&S (Ideas and Solutions, Hungary). The modules were executed in a hybrid fashion (online and onsite in Dubai). We thank Dr. Sara Al Dallal, President of Emirates Health Economics Society as well as Prof. Lieven Annemans and the directors of Ideas &Solutions, Inc., Dr. David Danko and Dr. Mark Molnar for their excellent contributions. This program was supported by an unrestricted grant from Johnson & Johnson.
VSCR and Ideas & Solutions in Dubai
CAPACITY BUILDING PROGRAM IN SUB-SAHARAN AFRICA
Currently a large number of health policy makers/payers from Sub-Saharan Africa (SSA) including countries such as Ghana, Nigeria, Ivory Coast, Cameroon, Senegal, Namibia, Botswana, Kenya, Rwanda have started VSCR’s HEOR Diploma together with an informal training about Supply Chain Technology and Health Systems Awareness, Resilience and Transformation. This program will continue until the end of 2025.
Prof. Lieven Anneman and VSCR in virtual ZOOM Meetings with delegates from Sub-Saharan Africa
Experts such as Prof. Lieven Annemanns, University of Ghent, Belgium and Prof. Justice Nonvignon, Public Health, University of Ghana, both distinguished members of VSCR’s faculty presented valuable business cases and examples. Further experts were Nina Bressler, Head of Societal Learning, Novartis Institute and many more. This VSCR Diploma Program was supported by an unrestricted grant from Novartis.
Selected European stakeholders attended successfully VSCR’s regular HEOR Diploma programs in 2023 and 2024. Partly supported by Eli Lilly, Indianapolis, USA.
FURTHER ACTIVITIES OF VSCR IN 2024
DIGITAL MARKETING TRAINING
April 2024: Digital Marketing Training for employees of STADA in UAE- (executed in Prague by Margarete Schreiner-Karner, MSc, Operational Manager VSCR and Thomas Catulli, CEO of SPS Marketing, Digital Marketing Agency
Margarete Schreiner-Karner and Thomas Catulli with STADA UAE in Prague, April 2024
September 2024: HEOR Diploma training for leaders of dialysis centers in Algeria. The Diploma modules were produced and led by Dr. Jürgen Raths, Switzerland, Senior lecturer HEOR of VSCR and executed in Sharm El Sheik, Egypt. This program was supported by an unrestricted grant from Julphar Pharma, Algeria
Dr. Jürgen Raths, Managing Director Cordée Consulting in Sharm El Sheik, November 2024
GROWTH IN MEDICAL AFFAIRS AND MEDICINES DEVELOPMENT
VSCR and IMPACT in UAE started in October 2024 with the first virtual modular educational program about “Creating a high-performance organization in Medical Affairs and Medicines Development in Saudi Arabia” and finalized in December 2024 with Oncology and Real-World Evidence, and its importance in the corresponding studies.
Speaker:
Module 1: Growth in Medical Liaison Management – Role of MSLs: Margarete Schreiner-Karner, MSc
Module 2 and 3: Conducting Clinical Research and Clinical Trial Design: Prof. Heinrich Klech
Module 4: Exploration of Studies in Oncology and Real – World Data:
The Clinical trialist´s perspective: Prof. Michael Gnant, MD, PhD, ABCSG
Introduction to Real-World Evidence and Statistical aspects of example trials:
Dr. Maximilian Pilz, Novustat GmbH
MSL – Module 1 and 2:
Margarete Schreiner-Karner, MSc and Prof. Heinrich Klech, MD, PhD, FCCP, GFMD
Module 3 and 4:
Prof. Michael Gnant, ABCSG and Dr. Maximilian Pilz, Novustat GmbH
We thank Prof. Michael Gnant, MD, PhD, Medical University Vienna, President of Austrian Breast and Colorectal Cancer Study Group (ABCSG) for giving great insights into today’s concepts in oncology as well as Dr. Maximilian Pilz of NOVUSTAT GmbH, Germany for excellent presentations about medical statistics.
Many thanks to our business partners in Middle East, Mr. Magdy Abuelfadl, BPharm (Impact), Mr. Mohamed Fahmy, BPharm (Headway) and to our Sponsor Johnson & Johnson Innovative Medicines in Saudi Arabia.
Mr. Mohamed Fahmy, BPharm (Headway, UAE) and Mr. Magdy Abuelfadl, BPharm(Impact), UAE,
DIPLOMA ADVANCED TRAINING with Austrian Medical ASSOCIATION
Continuous scientific recognitions/accreditations of CPD (Continuous Professional Development) modules/meetings from selected professional scientific providers (e.g Medahead and MedMedia, both in Vienna) for the CPD program (DFP- Diplom -Fortbildungs Program) of the Austrian Medical Association (Österr. Äztekammer)
OUTLOOK2025
Building a network-payer academy in Sub-Saharan Africa
Academic course in Pharmaceutical Policy & Governance for JENA and Saudi Arabia (in cooperation with Ideas and Solutions, Hungary)
Finally, we want to thank all VSCR faculty members for their great contributions as well as all the supporters and sponsors from industry.
Thanks to the Sigmund Freud University Vienna for additional accreditation of some of our programs.
Also, a special thanks to Mr. Mohamed Fahmy, BPharm, Managing Director of Headway, UAE for his partnership and support for projects in Middle East and Africa.